New-onset ANCA-positive small-vessel vasculitis is a rare but possible complication of COVID-19 vaccination. New-onset ANCA-positive small-vessel vasculitis is a rare but possible complication of ...
The authors reviewed the literature to identify high-quality studies (observational and controlled) of ANCA-associated vasculitis that included a predetermined target dose of steroids at the end of ...
SAN CARLOS, Calif., Nov. 12, 2021 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use ...
The approval was based on data from the phase 3 ADVOCATE trial, which evaluated Tavneos in 330 adults with newly diagnosed or relapsed ANCA-associated vasculitis. The Food and Drug Administration has ...
Please provide your email address to receive an email when new articles are posted on . Sofosbuvir, mirabegron and nintedanib — all approved within the past 9 years — are among the drugs associated ...
Proof of concept established for potential of vilobelimab to reduce use of corticosteroids in AAV patients: vilobelimab demonstrated comparable efficacy to standard of care Use of vilobelimab instead ...
Microscopic polyangiitis (mPA) is a systemic necrotizing nongranulomatous vasculitis that affects small blood vessels. Clinical features include constitutional symptoms such as fever, anorexia, ...
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) comes with a heavy quality-of-life burden that doesn't disappear after the early disease phase. This rare but heterogeneous ...
Objective The aim of this study was to investigate the relationship between antineutrophil cytoplasmic antibodies (ANCA) ...
In patients with ANCA-associated vasculitis (AAV), double seropositivity for MPO-ANCA and PR3-ANCA is linked to worse remission rates compared with either AAV type alone. Idiopathic ANCA-associated ...
Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — Patients who are diagnosed with ANCA-associated vasculitis at an older age are more likely to ...